CureVac N.V. Income Statement

Ask AI

Financial Statements

In millions of EUR, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenue
Cost of sales
Selling and distribution expenses
Research and development expenses
General and administrative expenses
Income from release of governmental contract liabilities
Other operating income
Other operating expenses
Operating profit / (loss)
Finance income
Finance expenses
Profit / (Loss) before income tax
Income tax benefit/ (expense)
Net profit / (loss) for the period
Other comprehensive income / (loss):
Foreign currency adjustments
Total comprehensive income / (loss) for the period
Net loss per share (basic and diluted)*
Net profit / (loss) loss per share - basic (in dollars per share)
Net profit / (loss) loss per share - diluted (in dollars per share)

Comments